Ranjan Abhishek, Lakra Priya S, Sahu Shyam S, Tirkey Kavita, Bose Vidisa, Birua Hirendra
Department of Pediatric Surgery, Rajendra Institute of Medical Sciences, Ranchi, IND.
Cureus. 2025 Mar 19;17(3):e80831. doi: 10.7759/cureus.80831. eCollection 2025 Mar.
Background Clinical professionals find it challenging to set uniform standards for the treatment of urinary tract infections (UTIs) because of differences in susceptibility. This study has been conducted to assess antibiotic sensitivity patterns and bacterial profiles in pediatric patients with UTI and aid in the empirical management of patients exhibiting UTI symptoms. Materials and methods This is an observational prospective study conducted at the Department of Pediatric Surgery at Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India. Overall, 384 patients were enrolled in the study. Ethical approval was obtained from the Institutional Ethics Committee (IEC), RIMS, Ranchi, Jharkhand, India, under letter number 308 dated April 4, 2024. Results There was no significant difference in age groups between male and female participants. Various bacterial pathogens were detected in pediatric UTIs, including , species, species, species, species, species, and species. was more sensitive to ertapenem (135 (93.1%)) and meropenem (130 (89.6%)), followed by amikacin (118 (81.3%)), nitrofurantoin (115 (79.3%)), and imipenem (111 (76.5%)). Conclusion Different antibiotics have shown different levels of sensitivity toward various strains of bacterial pathogens causing UTIs. It is recommended that antibiotics as a medication be suggested on the basis of antibiotic sensitivity patterns in different cases of UTIs. Also, regional data may be effective in the selection of suitable drugs.
背景 由于药敏性存在差异,临床专业人员发现为尿路感染(UTIs)的治疗设定统一标准具有挑战性。本研究旨在评估小儿UTI患者的抗生素敏感性模式和细菌谱,并有助于对表现出UTI症状的患者进行经验性管理。材料与方法 这是一项在印度贾坎德邦兰契市拉金德拉医学科学研究所(RIMS)小儿外科进行的观察性前瞻性研究。总体而言,384名患者纳入了该研究。印度贾坎德邦兰契市RIMS的机构伦理委员会(IEC)于2024年4月4日以第308号信函批准了伦理许可。结果 男性和女性参与者的年龄组之间没有显著差异。在小儿UTIs中检测到了各种细菌病原体,包括 菌属、 菌属、 菌属、 菌属、 菌属和 菌属。 对厄他培南(135例(93.1%))和美罗培南(130例(89.6%))更敏感,其次是阿米卡星(118例(81.3%))、呋喃妥因(115例(79.3%))和亚胺培南(111例(76.5%))。结论 不同抗生素对引起UTIs的各种细菌病原体菌株表现出不同程度的敏感性。建议根据不同UTIs病例的抗生素敏感性模式来建议使用抗生素作为药物。此外,区域数据可能有助于选择合适的药物。